• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KLF15 通过 SDF-1β 负向调节心脏纤维化,从而减轻 2 型糖尿病小鼠的心脏纤维化。

KLF15 negatively regulates cardiac fibrosis by which SDF-1β attenuates cardiac fibrosis in type 2 diabetic mice.

机构信息

Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.

Department of Spinal Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, China.

出版信息

Toxicol Appl Pharmacol. 2021 Sep 15;427:115654. doi: 10.1016/j.taap.2021.115654. Epub 2021 Jul 23.

DOI:10.1016/j.taap.2021.115654
PMID:34310909
Abstract

Diabetic cardiomyopathy (DCM) is a serious diabetic complication that lacks effective preventive or therapeutic approaches. Wild-type and Klf15 knockout (Klf15-KO) mice were fed with either high fat diet (HFD, 60% kcal from fat) or normal diet (ND, 10% kcal from fat) for 3 months and then injected with streptozotocin or vehicle, to induce type 2 diabetes (T2D). All T2D and age-matched control mice were treated with or without SDF-1β at 5 mg/kg body-weight twice a week and also continually received HFD or ND for 3 months. At the end of 6-month study, after cardiac functions were measured, mice were euthanized to collect heart tissue. For in vitro mechanistic study, H9c2 cells were exposed to palmitate to mimic in vivo condition of T2D. SDF-1β prevented T2D-induced cardiac dysfunction and fibrosis and T2D-down-regulated KLF15 expression in wild-type diabetic heart tissue. However, the preventive effects of SDF-1β on both KLF15 expression and fibrosis was abolished, with partial cardiac protection in Klf15-KO/T2D mice. These results demonstrate partial KLF15-dependence for SDF-1β's cardiac fibrotic protection from T2D, but not on SDF-1β's protective effects on T2D-induced cardiac dysfunction. Further study showed that SDF-1β inhibited palmitate-induced cardiomyocyte fibrosis through its receptor CXCR7-mediated activation of p38β MAPK signaling pathway.

摘要

糖尿病心肌病(DCM)是一种严重的糖尿病并发症,缺乏有效的预防或治疗方法。野生型和 Klf15 敲除(Klf15-KO)小鼠分别用高脂肪饮食(HFD,60%的热量来自脂肪)或正常饮食(ND,10%的热量来自脂肪)喂养 3 个月,然后用链脲佐菌素或载体注射,以诱导 2 型糖尿病(T2D)。所有 T2D 和年龄匹配的对照小鼠均用或不用 SDF-1β(5mg/kg 体重,每周 2 次)治疗,并继续接受 HFD 或 ND 喂养 3 个月。在 6 个月的研究结束时,测量心功能后,处死小鼠收集心脏组织。对于体外机制研究,将 H9c2 细胞暴露于棕榈酸中以模拟体内 T2D 条件。SDF-1β可预防 T2D 诱导的心脏功能障碍和纤维化,并下调野生型糖尿病心脏组织中的 KLF15 表达。然而,SDF-1β 对 KLF15 表达和纤维化的预防作用被废除,在 Klf15-KO/T2D 小鼠中部分保留了心脏保护作用。这些结果表明,SDF-1β 对 T2D 诱导的心脏纤维化的保护作用部分依赖于 KLF15,但对 SDF-1β 对 T2D 诱导的心脏功能障碍的保护作用不依赖于 KLF15。进一步的研究表明,SDF-1β 通过其受体 CXCR7 介导的 p38β MAPK 信号通路的激活抑制棕榈酸诱导的心肌细胞纤维化。

相似文献

1
KLF15 negatively regulates cardiac fibrosis by which SDF-1β attenuates cardiac fibrosis in type 2 diabetic mice.KLF15 通过 SDF-1β 负向调节心脏纤维化,从而减轻 2 型糖尿病小鼠的心脏纤维化。
Toxicol Appl Pharmacol. 2021 Sep 15;427:115654. doi: 10.1016/j.taap.2021.115654. Epub 2021 Jul 23.
2
A novel mechanism by which SDF-1β protects cardiac cells from palmitate-induced endoplasmic reticulum stress and apoptosis via CXCR7 and AMPK/p38 MAPK-mediated interleukin-6 generation.SDF-1β 通过 CXCR7 和 AMPK/p38 MAPK 介导的白细胞介素-6 生成,保护心脏细胞免受棕榈酸诱导的内质网应激和细胞凋亡的一种新机制。
Diabetes. 2013 Jul;62(7):2545-58. doi: 10.2337/db12-1233. Epub 2013 Feb 19.
3
Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.通过 AMPK 介导的脂质代谢途径和 NRF2 功能激活,莱菔硫烷对 2 型糖尿病诱导的心肌病的保护作用。
Metabolism. 2020 Jan;102:154002. doi: 10.1016/j.metabol.2019.154002. Epub 2019 Nov 9.
4
Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.阿加曲班通过减少纤维化、炎症、细胞凋亡和蛋白酶激活受体表达来减轻大鼠糖尿病心肌病。
Cardiovasc Drugs Ther. 2017 Jun;31(3):255-267. doi: 10.1007/s10557-017-6732-3.
5
4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement.4-O-甲基和厚朴酚通过激活 AMPK 介导的心脏脂质代谢改善来预防 2 型糖尿病小鼠的糖尿病心肌病。
J Cell Mol Med. 2019 Aug;23(8):5771-5781. doi: 10.1111/jcmm.14493. Epub 2019 Jun 14.
6
Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.非诺贝特通过成纤维细胞生长因子21/沉默信息调节因子1增加心脏自噬,并预防1型糖尿病小鼠心脏的纤维化和炎症。
Clin Sci (Lond). 2016 Apr;130(8):625-41. doi: 10.1042/CS20150623. Epub 2016 Jan 21.
7
Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.靶向心脏磷酯酰肌醇 3-激酶(p110α)的基因治疗可减轻 2 型糖尿病中的心脏重构。
Am J Physiol Heart Circ Physiol. 2020 Apr 1;318(4):H840-H852. doi: 10.1152/ajpheart.00632.2019. Epub 2020 Mar 6.
8
Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy.金属硫蛋白位于Nrf2下游,并部分介导萝卜硫素对糖尿病心肌病的预防作用。
Diabetes. 2017 Feb;66(2):529-542. doi: 10.2337/db15-1274. Epub 2016 Nov 30.
9
Diabetic cardiomyopathy - Zinc preventive and therapeutic potentials by its anti-oxidative stress and sensitizing insulin signaling pathways.糖尿病心肌病——锌通过抗氧化应激和敏化胰岛素信号通路的预防和治疗潜力。
Toxicol Appl Pharmacol. 2023 Oct 15;477:116694. doi: 10.1016/j.taap.2023.116694. Epub 2023 Sep 20.
10
Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.成纤维细胞生长因子 21 通过 AMPK 介导的抗氧化和降脂作用预防糖尿病心肌病。
Cell Death Dis. 2018 Feb 14;9(2):227. doi: 10.1038/s41419-018-0307-5.

引用本文的文献

1
Mitochondrial calcium signaling regulates branched-chain amino acid catabolism in fibrolamellar carcinoma.线粒体钙信号传导调节纤维板层癌中的支链氨基酸分解代谢。
Sci Adv. 2025 May 30;11(22):eadu9512. doi: 10.1126/sciadv.adu9512. Epub 2025 May 28.
2
Mitochondrial Calcium Signaling Regulates Branched-Chain Amino Acid Catabolism in Fibrolamellar Carcinoma.线粒体钙信号调节纤维板层癌中的支链氨基酸分解代谢。
bioRxiv. 2024 Nov 30:2024.05.27.596106. doi: 10.1101/2024.05.27.596106.
3
Krüpple-like factors in cardiomyopathy: emerging player and therapeutic opportunities.
心肌病中的Krüpple样因子:新兴角色与治疗机遇
Front Cardiovasc Med. 2024 Mar 7;11:1342173. doi: 10.3389/fcvm.2024.1342173. eCollection 2024.
4
Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts.2 型糖尿病 OLETF 大鼠心脏中外周线粒体 BCKDH 的下调及其与 AMP 脱氨酶的解偶联。
Physiol Rep. 2023 Feb;11(4):e15608. doi: 10.14814/phy2.15608.
5
Construction of Immune-Related ceRNA Network in Dilated Cardiomyopathy: Based on Sex Differences.基于性别差异构建扩张型心肌病的免疫相关ceRNA网络
Front Genet. 2022 Jun 8;13:882324. doi: 10.3389/fgene.2022.882324. eCollection 2022.